Convergence A Proxy For Harmonization In Asia As Regulators See Slow And Steady Winning The Race
This article was originally published in PharmAsia News
Executive Summary
Regulators across Asia have embraced some of the same language and procedures on reviewing clinical trials and drug registrations – but wide cultural, political and economic levels across the region are leading many to take a slow and steady approach to harmonization, a trend some label as convergence.